Tesamorelin Buyer Guide: Visceral-Fat Evidence, Prices, Deals, and COA Checks

Short Answer: Tesamorelin Is the Visceral-Fat Specialist

Tesamorelin is a 44-amino-acid growth hormone-releasing hormone analog with direct randomized human evidence for reducing CT-measured visceral adipose tissue. That makes it the evidence-led choice in the GH-peptide lane when visceral abdominal fat is the research target.

The pivotal trials found roughly 15% visceral-fat reduction at 26 weeks, with broader Phase III evidence reaching about 18% at 52 weeks among people who continued treatment. Those results came from adults with HIV-associated abdominal adiposity, so they should not be treated as a promise of identical outcomes in every population.

For buyers, the current verified value range starts around $4.67 to $5.00 per mg after code, before shipping. Start with the live comparison at /prices/tesamorelin, verify the seller at /vendors, then match the exact vial lot to its COA before checkout.

What Tesamorelin Does and Why Buyers Choose It

Tesamorelin stimulates the pituitary through the GHRH receptor, supporting pulsatile endogenous growth hormone release and downstream IGF-1. It does not supply HGH directly.

Its strongest benefit lane is visceral fat, the metabolically active fat surrounding internal organs. That is different from pinchable subcutaneous fat. Human studies also reported changes in waist circumference, trunk fat, triglycerides, and liver fat depending on the trial, but the visceral-fat result is the clearest reason to choose tesamorelin.

Human Evidence: The Numbers That Matter

Falutz and colleagues randomized 412 adults with HIV-associated abdominal fat accumulation, 86% of them men, to tesamorelin 2 mg subcutaneously daily or placebo for 26 weeks. Visceral adipose tissue changed by about -27.8 cm² with tesamorelin versus +5.1 cm² with placebo. That corresponds to approximately a 15% relative VAT reduction in the treatment group.

Broader Phase III evidence across 806 participants found about a 15% VAT reduction at 26 weeks and roughly 18% at 52 weeks among continuers.

A separate 2014 trial by Stanley and colleagues randomized 50 participants for six months, with 28 receiving tesamorelin and 22 receiving placebo. VAT changed by -34 cm² versus +8 cm², a net treatment effect of -42 cm² with p=0.005. Liver fat showed a net effect of -2.9 percentage points, p=0.003.

The subcutaneous-fat treatment effect was only -6 cm² and was not statistically significant, p=0.37. That distinction matters. Tesamorelin has a specific visceral-fat evidence signal, not a blanket promise to reduce every kind of belly fat.

The major VAT trials used 2 mg once daily. That is a published human-study benchmark for understanding the evidence and comparing vial economics, not an individualized protocol.

Current Tesamorelin Prices Compared

The PeptidePub catalog snapshot checked July 31, 2026 contains 22 offers across 17 vendors, with vial sizes from 5 mg to 32 mg:

• Ascension: 5 mg for $50
• AMP: 10 mg for $68
• Atomik: 10 mg for $65 or 20 mg for $110
• EZ: 10 mg for $68
• Glacier: 10 mg for $67.99 or 20 mg for $117.99
• Improved: 5 mg for $89 or 10 mg for $130
• Level Up: 10 mg for $75
• MD Innovative: 10 mg for $120 or 20 mg for $200
• Mile High: 10 mg for $79.99
• Valkyrie: 10 mg for $100
• Aero: 10 mg for $64.99
• World Wide: 5 mg for $228 or 10 mg for $464
• Double R: 10 mg for $54.99
• Peptide Society: 10 mg for $89.99
• Viper: 5 mg for $49.99
• Valor: 10 mg for $59.99 or 32 mg for $169.99

List price is only the first pass. Codes can reorder the table, and shipping can change the final winner. Use /prices/tesamorelin for the current offers rather than treating this July 31 snapshot as permanent.

Best Value After Verified Codes

Double R currently leads the verified-code checkpoints. Its 10 mg vial is $54.99 list and $46.74 after the 15% PEPTIDEPUB code, or $4.67 per mg. It has a Kovera Labs COA, verification, and a 7 of 7 vendor testing record.

Atomik 20 mg is $110 list and $93.50 after 15% off with PEPTIDEPUB15, or $4.68 per mg. Valor 32 mg is $169.99 list and $152.99 after 10% PEPTIDEPUB, or $4.78 per mg. Their testing-depth records are 6 of 7 and 5 of 7, respectively.

Ascension offers the lowest entry price: 5 mg is $50 list and $25 after the confirmed 50% PEPTIDEPUB code, or $5.00 per mg. Glacier 20 mg is $117.99 list and $106.19 after 10% PEPTIDEPUB, or $5.31 per mg. Both have Kovera Labs COAs and 6 of 7 vendor testing fields. Valor uses AccumarkLabs.

Vial Size and Study-Benchmark Math

At the published 2 mg daily study benchmark, a 5 mg vial contains 2.5 nominal daily amounts, a 10 mg vial contains 5, a 20 mg vial contains 10, and a 32 mg vial contains 16. This is study context, not personal dosing advice.

A larger vial can cost more at checkout while delivering a lower cost per mg. Compare planned amount, delivered cost, and usable vial size with /tools/cost-per-dose. For BAC-water concentration and U-100 syringe-unit math, use /tools/reconstitution-calculator rather than guessing a reconstitution volume.

COA and Vendor Proof Before Checkout

A useful tesamorelin COA should show exact identity, labeled vial amount, matching lot or batch, named independent lab, report date, verifiable report ID, purity, LC-MS identity, and quantitative net content. Tesamorelin has molecular formula C221H366N72O67S and molecular mass near 5,135.9 Da. The report should match the intended 44-amino-acid tesamorelin target, not a vague GHRH label or a tesamorelin plus ipamorelin blend.

For an injectable vial, stronger proof also includes sterility, endotoxin, heavy-metal, and contaminant screening. High purity alone does not prove the vial contains its labeled amount or that it passed sterility testing.

Current vendor testing-depth checkpoints are Double R and World Wide at 7 of 7 fields; Ascension, Atomik, Glacier, and Mile High at 6 of 7; Valor at 5 of 7; AMP, EZ, Viper, and Valkyrie at 3 of 7; and Level Up at 2 of 7. These are vendor-level records, not automatic proof for every current tesamorelin lot.

Named labs include Kovera Labs for Double R, Ascension, Atomik, Glacier, Mile High, and World Wide; AccumarkLabs for Valor; Janoshik for AMP and EZ; Freedom Diagnostics for Viper; Horizon Analytical for Valkyrie; and Vanguard Laboratory for Level Up.

Use How to Read a Peptide COA Before You Buy for the full checklist, compare sellers at /vendors, and review PeptidePub’s seven-field scoring framework at /methodology.

Tesamorelin vs CJC-1295 Plus Ipamorelin

Tesamorelin is the evidence-led visceral-fat choice. CJC-1295 plus ipamorelin is the broader GH-support research choice, combining GHRH-receptor signaling with ghrelin-receptor signaling.

The distinction is research fit, not interchangeability. Tesamorelin has direct randomized outcomes for CT-measured visceral fat. CJC-1295 plus ipamorelin does not have equivalent controlled human fat-loss evidence. Buyers prioritizing the most specific evidence for visceral adiposity have a clearer reason to select tesamorelin. Buyers comparing wider GH-axis research goals may prefer to examine the combination.

Read the CJC-1295 + Ipamorelin vs Tesamorelin Buyer Guide for the full head-to-head comparison. The CJC-1295 + Ipamorelin Buyer Guide covers blend versus separate-vial proof and the COA questions that follow.

A Practical Tesamorelin Buying Checklist

Use this order before checkout:

1. Confirm that tesamorelin and visceral-fat research match your goal.
2. Compare current effective price per mg at /prices/tesamorelin.
3. Apply the verified code and add shipping.
4. Match the exact tesamorelin lot, vial amount, and named lab to the COA.
5. Compare vendor testing depth at /vendors.
6. Calculate usable cost for the vial size you are considering.
7. Choose the strongest combination of delivered value and lot-specific proof.

When that seller fits your needs, /go/bodybuilding-health is the verified affiliate route.

FAQ

Is tesamorelin the same as HGH?

No. Tesamorelin signals the pituitary through the GHRH receptor to release endogenous growth hormone. HGH supplies the hormone directly. That mechanistic difference is central to how buyers compare the two research lanes.

What is the best current tesamorelin price per mg?

In the July 31 snapshot, Double R 10 mg is about $4.67 per mg after code, Atomik 20 mg is about $4.68 per mg, and Valor 32 mg is about $4.78 per mg, all before shipping. Ascension provides a smaller 5 mg entry point at $25 after its 50% code, or $5.00 per mg. Check /prices/tesamorelin for the live table because prices, codes, stock, and shipping change.

What dosage did the major human tesamorelin trials study?

Major visceral-fat trials used 2 mg subcutaneously once daily for 26 weeks or six months. Falutz and colleagues studied 412 adults, while Stanley and colleagues studied 50 participants. Treat 2 mg daily as published study context, not a personal protocol.

Does tesamorelin reduce subcutaneous belly fat?

Its clearest signal is visceral fat around the organs. In the 2014 study, the subcutaneous-fat treatment effect was -6 cm² and not significant, p=0.37, while the visceral-fat effect was -42 cm², p=0.005.

What should a tesamorelin COA show?

Look for exact tesamorelin identity, matching lot and vial amount, named independent lab, report date, verifiable report ID, purity, quantitative net content, and LC-MS identity. Prefer broader sterility, endotoxin, heavy-metal, and contaminant results for injectable-vial proof.

Bottom Line: Buy on Evidence, Delivered Price, and Lot Proof

Tesamorelin earns attention because its visceral-fat lane is backed by large randomized trials and specific CT-measured outcomes. The July 31 verified value leaders sit around $4.67 to $4.78 per mg after code, while Ascension offers a smaller 5 mg entry point for $25 after its confirmed 50% discount.

The best buy is not automatically the cheapest vial or the highest purity percentage. Compare live offers at /prices/tesamorelin, verify the seller and exact lot at /vendors, apply the current code, add shipping, calculate usable cost, and choose the strongest verified value. That workflow keeps the decision focused on the three things that matter most: relevant human evidence, delivered price, and proof for the vial you are actually buying.